RNA-transfected dendritic cells in cancer immunotherapy.
about
Recent advances in the field of anti-cancer immunotherapyPathways and therapeutic targets in melanomaDendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumorsDendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic miceTowards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications.Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.Strategies for designing and optimizing new generation vaccines.In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle.Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results.An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigensDendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpSHybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.Toward effective immunotherapy for the treatment of malignant brain tumorsEnhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.Messenger RNA (mRNA) nanoparticle tumour vaccinationValidation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation.Optimized protocol for efficient transfection of dendritic cells without cell maturationAnalysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.Luciferase mRNA Transfection of Antigen Presenting Cells Permits Sensitive Nonradioactive Measurement of Cellular and Humoral Cytotoxicity.Optimizing the process of nucleofection for professional antigen presenting cells.Applying Subtractive Hybridization Technique to Enrich and Amplify Tumor-Specific Transcripts of Esophageal Squamous Cell Carcinoma.Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune ResponseBridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patientsDendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo.Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy.An Autologous Therapeutic Dendritic Cell Vaccine Transfected with Total Lung Carcinoma RNA Stimulates Cytotoxic T Lymphocyte Responses Against Non-Small Cell Lung Cancer
P2860
Q26775602-DB23A77F-E5CD-4708-809D-AF49D21E3371Q26865736-E21B9127-FF5E-4841-9B72-DEACED254DE7Q28183577-22089637-4D01-48AB-9F24-60AF31B642C8Q33522216-E8EE99B7-8ACB-4440-A5CC-FFFACAD8D3EFQ34055104-C8EF39B4-5E6C-4C82-AAC0-2D0B8AC39549Q34231139-5AA9C743-4A24-4A51-9306-FD38C973162AQ34552791-B0D98AE6-CD32-43DF-8BCF-28C5D94C32D9Q34572198-AB2D2741-0459-44C2-BBC0-02043FDE3FE7Q34589906-5EA125C2-7434-420A-AA05-5F4F354DE893Q35504499-9A7F4373-3216-42E5-B90F-756B6C5F2E73Q35747229-61710A2F-9197-41E1-BDAC-F8F4B1E9B3DAQ35939427-18CB21FF-29B0-4C15-B05A-22F4A5FD682DQ36666301-143561CF-ACA5-4005-818E-3B5E5E6848FDQ36908547-8EC3AB5C-067E-4C51-B250-FEAA5E7D4D40Q37362636-D0DD25A0-E82E-467F-914C-AC01E8F12384Q37395354-05297A55-54D8-4677-ABCE-8BB49C0A7D3CQ37533657-6EDDE846-AD44-4E19-9F74-4BB38C493E3EQ38059499-C2F7475D-EAC5-4016-9202-9173C440F68AQ38218147-E6238D66-04C8-4DEB-9D7B-DA755FE56384Q38468370-4264C45B-DCCD-412B-A379-5E2BA2A4539CQ38744180-E4E20E7C-3E41-41BC-818C-DA65B413C5E5Q38758254-DCDF74B2-D53B-464C-95DE-21D8E3BE1268Q38779887-118CDBD5-BFF1-4797-8D2A-0FDEC3DC467BQ38832705-B83EA1E4-49BA-4FA2-90AA-9B3EFB9BD25BQ38841320-B1AF4119-C5BB-492D-8F76-3ED0ADC39C71Q39791507-CEB8E102-4F56-4E84-946A-77DF1391B87FQ39829133-C8F087E2-5159-4035-AFF2-355E24B75B53Q40639503-212F55EE-5E95-4861-824F-E1012F962EDBQ41967129-E2DCAB2B-31D5-48F0-AC54-1BD384A4212EQ45418280-6A74DF6D-3DCD-4C23-800F-1CE1E6E9BE28Q45881751-732BDC6C-4F74-4078-BFC4-FD14B8F03F98Q46612829-5C1D549C-3648-49F5-BCEC-DA6E8D52AD99Q52866914-AE07632C-05B0-4F48-8D1B-58B0021C8AD4Q57909021-51236606-ACCF-45D2-9A54-518E2DFDBC68
P2860
RNA-transfected dendritic cells in cancer immunotherapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
RNA-transfected dendritic cells in cancer immunotherapy.
@ast
RNA-transfected dendritic cells in cancer immunotherapy.
@en
RNA-transfected dendritic cells in cancer immunotherapy.
@nl
type
label
RNA-transfected dendritic cells in cancer immunotherapy.
@ast
RNA-transfected dendritic cells in cancer immunotherapy.
@en
RNA-transfected dendritic cells in cancer immunotherapy.
@nl
prefLabel
RNA-transfected dendritic cells in cancer immunotherapy.
@ast
RNA-transfected dendritic cells in cancer immunotherapy.
@en
RNA-transfected dendritic cells in cancer immunotherapy.
@nl
P2860
P356
P1476
RNA-transfected dendritic cells in cancer immunotherapy.
@en
P2093
D A Mitchell
P2860
P304
P356
10.1172/JCI11405
P407
P577
2000-11-01T00:00:00Z